Short answer
ANGIODYNAMICS INC (ANGO) filed its Q1 2026 10-Q quarterly report on Apr 2, 2026 for the quarter ended Feb 28, 2026. Quarterly revenue was $78M (up 8.9% year over year) with net income of −$8M.
Q1 2026 key financials · XBRL
- Revenue
- $78M
- +8.9% YoY · −1.3% QoQ
- Net income
- −$8M
- −83.4% YoY · −27.3% QoQ
- Operating margin
- -16.5%
- Gross margin
- 52.9%
- EPS (diluted)
- −$0.19
- −90.0% YoY · −18.8% QoQ
Source: XBRL data from the ANGIODYNAMICS INC (ANGO) Q1 2026 10-Q on SEC EDGAR. USD.
ANGIODYNAMICS INC Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $78.4M, up 8.9% YoY from $72.0M
- Gross margin 52.9% vs 54.0% YoY; net loss $8.1M vs $4.4M
- Best segment Med Tech revenue $37.3M, up 19.0%; worst Med Device growth 1.2%
- Cash $37.8M vs $55.9M; operating cash use $14.4M vs $28.9M
- Headwinds from tariffs, inflation, labor shortages, supply-chain challenges and backlog; liquidity sufficient for 12 months
Risk Factors
- No risk-factors section provided; supplied text covers Items 2–6
- CEO James C. Clemmer transition and retirement agreement dated February 3, 2026
- Retention incentive letters disclosed February 3, 2026
- No senior-security defaults during the quarter
- No public repurchases under the $15.0 million authorization during the quarter
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other ANGIODYNAMICS INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.